As competition intensifies among surgical robot makers, CMR said its soft tissue platforms are the second most used systems ...

CMR Surgical announced today that its second-generation surgical robot, Versius Plus, received FDA 510(k) clearance.

“Built on years of global clinical use data, Versius Plus delivers the flexibility and intelligence today’s healthcare ...

CMR Surgical’s Versius Plus robot’s clearance follows the FDA’s de novo classification of the company’s first-generation ...

December 2025 CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system Regulatory clearance of CMR's most advanced system paves the way for upcoming US commercial launchStrong ...

CMR Surgical said it is on track to begin commercialization of its Versius Plus surgical robotic platform in 2026 in the United States.

Versius customer reach increases as CMR Surgical closes 2023 with strongest quarter on record After a record quarter, CMR closes the year with a Versius global install base more than 50% higher than ...

CMR Surgical launches vLimeLite * a new imaging technology to visualise ICG, the first product launch in a series of 2024 product releases as part of Versius Plus, a significant enhancement to the ...

CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...

Robots have been deployed in the medical field for a long time now. But this time, a robot just gave a man a second shot at life. A surgical team from Gloucestershire Royal Hospital (GRH) removed a ...

The FDA previously granted marketing authorization for CMR’s first-generation Versius Surgical System in October 2024.